Biomanufacturing and Bio-foundry will drive India’s future bioeconomy: Dr. Jitendra Singh
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility
Cipla completes transfer of Generics Business Undertaking
he lower sales in the current quarter are mainly on account of a one?time impact on the company’s India business
iSolveSM information on demand is the result of our focus on customer relationship
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
Atlas AI combines NVIDIA BioNeMo cloud APIs for intelligent chemical and protein design
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Subscribe To Our Newsletter & Stay Updated